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Edited by Peter BrzezinskiAbstract The ATP-binding cassette (ABC) transporters con-
stitute one of the largest families of proteins in evolution. The
ATM1 gene of the yeast Saccharomyces cerevisiae encodes an
ABC protein, which is localized to the mitochondrial inner
membrane. A deletion of ATM1 results in the accumulation of
up to a 30-fold excess of mitochondrial iron, loss of mitochon-
drial cytochromes and abnormalities of cytosolic iron metabo-
lism. In this study, we have evaluated the role of conserved
sequence elements in Atm1p in its function and dimerization in
vivo. We report that conserved residues in the Walker A and B
motifs of the nucleotide binding domain, which are required for
ATP binding and hydrolysis, are essential for Atm1p function. In
addition, we provide evidence that ATP binding is important for
Atm1p dimerization.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The ATP-binding cassette (ABC) transporters constitute one
of the largest families of proteins in evolution with numerous
examples present in archea, eubacteria, and eukaryotes. The
majority of these proteins are involved in the energy-dependent
transport of substrates across cellular membranes, and their
impaired function is related to a wide variety of inherited
diseases. Well-known examples of ABC transporters include
the cystic ﬁbrosis transmembrane conductance regulator
(CFTR) and the multidrug resistance proteins. The canonical
structure of a functional transporter includes two transmem-
brane domains (TMDs) and two nucleotide-binding domains
(NBDs). While TMDs determine substrate speciﬁcity, the
NBDs serve as the motors, coupling the energy of ATP
binding and hydrolysis to transmembrane transport.
The ATM1 gene of the yeast Saccharomyces cerevisiae en-
codes an ABC transporter whose disruption results in the ac-
cumulation of up to a 30-fold excess of mitochondrial iron,
loss of mitochondrial cytochromes, oxidative damage to the* Corresponding author. Fax: +1-503-494-2781.
E-mail address: koellerd@ohsu.edu (D.M. Koeller).
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doi:10.1016/j.febslet.2004.05.051mitochondrial DNA, and decreased levels of cytosolic heme
proteins [1,2]. Deletion of ATM1 also results in cytosolic iron
starvation and loss of cytosolic Fe-S proteins [3,4]. Atm1p is
localized to the mitochondrial inner membrane with its car-
boxy terminal NBD in the matrix, which predicts that it
functions to export substrate from the matrix to the inter-
membrane space [2]. The speciﬁc function of Atm1p has not
been identiﬁed, but based on the phenotype of Datm1 cells,
roles in mitochondrial iron export and/or Fe-S cluster assem-
bly have been proposed [3,4].
The structure and function of ABC transporters has been
intensively investigated. As a result, the speciﬁc functions of
conserved sequence elements are being deﬁned. Previous
studies of Atm1p have been based primarily on the analysis of
yeast in which the ATM1 gene has been deleted, but a sys-
tematic analysis of speciﬁc sequence elements has not been
undertaken. In this paper, we describe studies to assess the role
of conserved elements in NBD in the function of Atm1p. We
report that mutation of residues that aﬀect either ATP binding
or hydrolysis results in a loss of Atm1p function in vivo. Ad-
ditionally, we have determined that Atm1p functions as a
homodimer and that mutations in the NBD aﬀect dimer
stability.2. Materials and methods
2.1. Yeast strains and culture conditions
With the exception of the ATP-binding analysis, all studies were
performed in the W303 strain (MATa, ade2, can1-100, his3-11,15, leu2-
3,112, trp1-1, ura3-1). Disruption of the chromosomal ATM1 gene was
done using a targeting allele made by inserting the HIS3 gene into the
unique Tth1 1 1 I and XbaI sites in the ATM1 gene. The ATP-binding
experiments were done in strain YKB5 (MATa, Dura3, his4-519, leu2-
3,112, atm1::LEU2) [2]. Growth and manipulations of yeast were
performed using standard procedures [5]. Yeast were grown in Hart-
well’s Complete (HC) medium (0.145% yeast nitrogen base with amino
acids, 0.38 M (NH4)2SO4, and either 2% glucose or lactate). Esche-
richia coli manipulations were performed using the strains DH5a and
TOP1 OF’ (Invitrogen) according to standard procedures [6].
2.2. Construction of plasmids
Site-directed mutagenesis was performed using the QuikChange Site-
Directed Mutagenesis Kit (Stratagene). The template for mutagenesis
consisted of the entire Atm1p open reading frame, along with ap-
proximately 500 bp of 5’-ﬂanking sequence and a C-terminal epitope
tag, in YEplac112 (TRP1, HA tag) or YEplac195 (URA3, V5 tag). The
following primers were used for mutagenesis:
K475M – forward (50-GGTCTTCGGGCAGTGGGATGTCCAC-
CATTTTAAAATTAGTC), reverse (50-GACTAATTTTAAAATG-
GTGGACATCCCAAGACC); E598A – forward (50-CATGTTTTT-
TGACGCGGCCACAAGCGCC), reverse (50-GGCGGCTTGTGG-
CCGCGTCAAAAAACATG). For the complementations assays, wild
type and mutant alleles of ATM1 were expressed in a centromericblished by Elsevier B.V. All rights reserved.
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marker swap [7]. To test for dominant-negative eﬀects, the K475M
were expressed in wild type cells under the control of the galactose
inducible GAL1 promoter in pYES 2.0.
2.3. Immunoprecipitation
Mitochondria (2 mg for proteins expressed in a centromeric plasmid,
or 500 lg for high copy plasmids) were solubilized in immunoprecip-
itation buﬀer (IP; 25 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM
EDTA and 0.2% Triton X-100) and incubated overnight at 4 C with 1
lg of either anti-HA or anti-V5 antibodies (Invitrogen). Antigen-
antibody complexes were precipitated with protein-A Sepharose beads
for 90 min at 4 C, collected by centrifugation, washed three times with
IP buﬀer, and resuspended in Laemmli sample buﬀer [8]. Proteins were
separated by SDS–PAGE and transferred to PVDF membranes by
electroblotting. Western-blot analysis was performed with either anti-
HA (1:1000) or anti-V5 (1:5000) antibodies, and a horseradish per-
oxidase conjugated secondary antibody, and visualized by ECL [9].
2.4. ATP binding
These studies were done in a Datm1 strain generated in the YKB5
background, which has a relatively mild phenotype [2]. This allowed
for the growth and isolation of mitochondria from cells expressing the
mutant ATM1 alleles in the absence of any wild type protein. Mito-
chondria were isolated from Datml cells expressing V5 epitope-tagged
versions of either the wild type or mutant Atm1p from high copy
plasmids. Binding of [32P]-labeled ATP was assayed using a method
based on a published procedure [10]. Mitochondrial samples were
subjected to immunoprecipitation with anti-V5 antibody, and after
collection on protein-A Sepharose, the samples were divided into two
fractions. Unlabeled ATP was added to a ﬁnal concentration of 5mM
to one of the aliquots, followed by the addition of 2 lCi of 8-azido-
[32P]-ATP (ALT) to both samples. Photo-crosslinking was performed
for 3 min at 245 nm. Samples were then washed several times with IP
buﬀer, separated by SDS–PAGE, and visualized by autoradiography
of the dried gel.
2.5. Miscellaneous techniques
Protein concentration was determined using the BCA kit (Pierce)
with bovine serum albumin as a standard. Yeast and bacterial trans-
formations were done using standard techniques [5,6]. Mitochondria
were isolated from cells grown to mid log phase ½A600 ¼ 0:6 in HC-2%
lactate by diﬀerential centrifugation [11].3. Results and discussion
3.1. Role of conserved residues in the nucleotide binding domain
ABC transporters function in the transmembrane transport
of a diverse array of substrates, ranging from metal ions to
peptides. As a result, the sequences of their TMDs, which
determine substrate speciﬁcity, have undergone signiﬁcant
evolutionary divergence. In contrast, the NBDs, whose
ATPase activity energizes transport, show signiﬁcant sequence
conservation [12] and have a common three-dimensional
structure [13–15]. Within the NBD, the highest conservation is
seen in the Walker A and B motifs, which are common toFig. 1. Sequence comparison of conserved regions of yeast ABC transporters.
A, B and the signature sequences is compared to other members of the MDR
the amino and carboxy terminal nucleotide binding domains of Ste6p, res
conserved Walker A lysine and the glutamate adjacent to the Walker B sequmany ATPases, and the signature sequence, which is charac-
teristic of ABC transporters [16–18]. These conserved elements
are required for ATP binding and hydrolysis [19].
The sequences of the Walker A and B motifs of Atm1p and
several closely related yeast ABC transporters are shown in
Fig. 1. The Walker A lysine, corresponding to lysine 475 in
Atm1p, is found in all ABC transporters [20]. We found that
substitution of this lysine with methionine (K475M) resulted in
a complete loss of Atm1p function (Fig. 2A, B). Western-blot
analysis demonstrated the presence of similar levels of the wild
type and K475M mutant proteins (Fig. 2C), indicating that the
inability of this allele to complement Datml cells was not due to
decreased protein expression. Furthermore, the K475M mu-
tant could be co-immunoprecipitated with the wild type pro-
tein (see below, Fig. 4C), indicating that it was properly
localized to the mitochondrial inner membrane. Residues in
the Walker A motif have been shown by X-ray crystallography
to interact with the b and c phosphate groups of ATP [13],
suggesting that the inactivation of Atm1p by the K475M
mutation may be due to decreased ATP binding. Therefore, we
assessed ATP binding by the K475M mutant using the photo
cross-linkable ATP analog 8-azido [32P]ATP. ATP binding
was signiﬁcantly decreased by the K475M mutation (Fig. 3A).
A Western-blot of the same mitochondrial samples used for
ATP binding showed a high level of expression of the K475M
protein (Fig. 3B), conﬁrming that the decreased signal in
Fig. 3A was due to an eﬀect of the mutation on ATP binding
and not a lack of protein.
The ATP binding experiments were carried out in cells of the
YKB5 background, which can be cultured in the absence of
any functional Atm1p [2,21]. The use of this strain was nec-
essary, since a Datm1 mutation is lethal in the W303 strain that
was used for the complementation analysis in Fig. 2 (see Sec-
tion 2). A comparison of Figs. 2 and 3 CB shows variability
between the level of expression of the plasmid borne alleles of
ATM1 between these strains and amongst the YKB5 cells
expressing the diﬀerent ATM1 genes. However, both the ATP
binding and Western blotting shown in Fig. 3 were done using
the same sample of isolated mitochondria, and thus the levels
of protein seen in Fig. 3B are an accurate reﬂection of the level
of each protein present in Fig. 3A.
Studies of both prokaryotic and eukaryotic ABC trans-
porters have shown that the glutamate immediately adjacent to
the Walker B motif (Fig. 1) is essential for ATP hydrolysis
[13,19]. We found that substitution of the corresponding glu-
tamate of Atm1p with alanine (E598A) resulted in a loss of
function (Fig. 2A, B) but did not aﬀect the level of expressed
protein (Fig. 2C), or its ability to associate with the wild type
protein (see below, Fig. 4B). In contrast with the K475MThe aminoacid sequence of the region of Atm1p containing the Walker
sub-group of yeast ABC proteins. STE6N and STE6C correspond to
pectively. The consensus residues of each motif are underlined. The
ence are indicated with an asterisk.
Fig. 2. Complementation assays for the Walker A (K475M) and Walker B (E598A) mutants. A, Datm1 cells containing a wild type allele of ATM1 on
a plasmid with a URA3 selectable marker (Datm1+WT) were transformed with a second plasmid bearing a LEU2 selectable marker and expressing
the wild type ATM1 gene (Datm1/WT+WT), an ATM1 allele with the K475M mutation (Datm1/K475M+WT), or an ATM1 allele with the E598A
mutation (Datm1/E598A+WT). Equal numbers of cells from each strain were serially diluted and dotted onto HC/2% glucose medium lacking uracil
and leucine to select for cells containing both plasmids. B, Cells from each of the strains were plated on HC/2% glucose medium lacking leucine and
containing 50-ﬂuoroorotic acid, which is toxic to cells that express the URA3 gene, to select for cells which have lost the wild type allele of ATM1. C,
Western-blot analysis of immunoprecipitations of Atm1p from mitochondria isolated from cells expressing the wild type, K475M, or E598A alleles.
Immunoprecipitations and Western blotting were done with a mouse monoclonal antibody against the V5 epitope tag, located at the carboxyl
terminus of each expressed protein.
Fig. 3. Analysis of ATP binding. A, Mitochondria from Datm1 cells or
Datm1 cells expressing a plasmid borne copy of the WT, K475M, or
E598A alleles were puriﬁed and subjected to immunoprecipitation with
an anti-V5 antibody. Immunoprecipitated proteins were incubated
with 8-azido-[32P]ATP in the presence or absence of an excess of un-
labeled ATP. Analysis of the amount of bound [32P]ATP was visual-
ized by autoradiography on dried gels following SDS–PAGE. B,
Aliquots of the isolated mitochondria used for ATP-binding experi-
ments were subjected to immunoprecipitation and Western blotting
using anti-V5 antibodies.
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in ATP binding (Fig. 3). This is similar to results reported from
studies of the NBD of the closely related yeast Md11p, which
demonstrated a 3000-fold decrease in ATPase activity but no
decrease in ATP binding following mutation of this conserved
glutamate [22].
We have observed that both the wild type and mutant forms
of Atm1p often migrate as a doublet on SDS–PAGE (Fig. 3).
The presence of the double band is inconsistent and is seen in
blots from lysates of whole mitochondria as well as following
immunoprecipitation. With the wild type protein, both of these
bands were capable of binding ATP (Fig. 3A). The ratio
between the two bands was identical under reducing and non-
reducing conditions and was unaﬀected by alkaline phospha-tase treatment (not shown). These data indicate that diﬀer-
ences in intramolecular disulﬁde bonds and phosphorylation
are not likely responsible for the presence of the two species of
Atm1p. The faster migrating species may result from partial
proteolysis, but further characterization will be required to
address this question.
Most ABC proteins function as ATP-dependent membrane
transporters and share the common requirement for an active
ATPase. The isolated NBD of the closely related Schizosac-
charomyces pombe Atm1 protein has been demonstrated to
have ATPase activity, though its functional role has not been
investigated [23]. We have shown that the wild type Atm1p
binds ATP and that mutation of the conserved Walker A ly-
sine resulted in signiﬁcantly decreased ATP binding and a loss
of function. We also observed that a mutation of glutamate
598, which is predicted to be the catalytic residue and essential
for ATPase activity [13,19], inactivated Atm1p. Collectively,
these results demonstrate that Atm1p requires an active
ATPase for its function.
3.2. Atm1p forms a homodimer
The four-domain structure of a functional ABC transporter
can be formed from a single polypeptide or by the association
of two to four separate subunits [24]. In eukaryotes, most ABC
proteins are encoded as single polypeptides, containing two
TMDs and two NBDs [25]. A small number are formed by the
dimerization of half molecules composed of single transmem-
brane and nucleotide binding domains [26].
Atm1p is a half ABC transporter with an amino terminal
TMD and a carboxy terminal NBD. Thus, it is predicted to
function as a dimer. The yeast genome encodes four additional
half ABC transporters with this structural organization that
could potentially form a heterodimer with Atm1p [27]. Two of
these proteins (Pxa1p and Pxa2p) are localized to the peroxi-
some [28] and the other two (Md11p and Mdl2p) are mito-
chondrial [29]. We recently identiﬁed Mdl1p as a high copy
suppressor of an Datml mutation, but we found no evidence
that it forms a heterodimer with Atm1p or has a physiologic
Fig. 4. Co-immunoprecipitation analysis of Atm1p. A, Mitochondria were isolated from a yeast strain expressing both HA and V5 epitope tagged
alleles of ATM1 and analyzed by immunoprecipitation. Western-blot analysis was performed with an anti-HA antibody. Lane 1: mitochondrial
lysate, Lane 2: HA immunoprecipitation, Lane 3: V5 immunoprecipitation. B, Mitochondria were isolated from yeast strains expressing the indicated
alleles of Atm1p and subjected to immunoprecipitation with anti-HA and anti-V5 antibodies. Western-blot analysis was done with an anti-HA
antibody. C, Western-blot analysis using either an anti-HA antibody (upper panel) or an anti-V5 antibody (lower panel). WT-HA, wild type protein
with HA epitope tag; K475M-V5, K475M mutant protein with V5 epitope tag; K475M-HA, K475M mutant protein with HA epitope tag; E598A-
V5, E598A mutant protein with V5 epitope tag; E598A-HA, E598A mutant protein with HA epitope tag.
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on growth in minimal glucose media [29], whereas a deletion of
ATM1 results in a severe growth defect (Fig. 2B), making it
unlikely that Atm1p functions as a heterodimer with Mdl2p.
To determine whether Atm1p forms a homodimer, we
constructed alleles with either an HA or V5 epitope tag and co-
expressed them in yeast. The epitope tags were located at the
carboxyl terminus of the protein and did not aﬀect the ability
of the tagged proteins to complement a Datm1 strain (not
shown), conﬁrming that both tagged proteins were functional
and properly localized. Immunoprecipitation using monoclo-
nal antibodies against the HA and V5 tags demonstrated that
Atm1p forms a homodimer (Fig. 4A). However, we do not
know whether Atm1p functions as a dimer, or as part of a
larger oligomeric complex. The human ABCG2, which like
Atm1p is a half ABC transporter, forms a homotetramer [30].
Using gel ﬁltration chromatography, we have observed
monomer, dimer, and higher molecular weight forms of
Atm1p (not shown). We are currently characterizing the olig-
omeric form of Atm1p.
3.3. ATP binding is required for dimerization of Atm1p
The dimerization of ABC transporters involves interactions
between the TMDs and the NBDs. Structural studies of bac-
terial ABC transporters have shown that dimerization of the
NBDs results in the sandwiching of an ATP molecule between
the Walker A motif of one subunit and the signature sequence
of a second subunit [13,31]. The DNA repair protein Rad50,
which contains an ABC-type NBD, also requires ATP for di-
merization [32]. These and other studies have led to the hy-
pothesis that the energy associated with ATP binding drives the
dimerization of the two NBDs [13,14,32]. Having observed that
the K475M mutation signiﬁcantly decreased ATP binding, we
looked at whether this mutation also aﬀected the ability of the
protein to form a stable homodimer [K475M:K475M], or a
heterodimer with the wild type protein [K475M:WT]. We ob-
served that the K475M and WT proteins could be co-immu-noprecipitated (Fig. 4B), whereas despite multiple attempts, we
were unable to co-immunoprecipitate a K475M homodimer
(Fig. 4C). Similar experiments with the E598A mutant dem-
onstrated both homodimers [E598A:E598A] and heterodimers
[E598A:WT] in yeast mitochondria (Fig. 4B). These results
suggest that ATP-dependent interactions between the NBDs
are crucial for the formation of a stable Atm1p dimer.
Current models for the mechanism of transport by most
ABC proteins include a requirement for two functional NBD
ATPases [33]. Thus, a heterodimer of active and inactive
monomers is predicted to be non-functional. Studies with
ABCD1 (ALDP), a homodimeric human half ABC trans-
porter of the peroxisome, have shown that co-expression of
wild type and mutant proteins leads to a loss of function of the
wild type protein via a dominant-negative eﬀect [34]. The
ability of the inactive K475M and E598A mutant proteins to
dimerize with wild type Atm1p predicts that their overex-
pression in wild type cells could also have a dominant-negative
eﬀect. To test this hypothesis, wild type cells were transformed
with a plasmid containing the wild type, K475M, or E598A
mutant allele of ATM1 under the control of the galactose
inducible GAL1 promoter. Surprisingly, we found no diﬀer-
ence between the growth of cells overexpressing the wild type
and mutant forms of Atm1p in either glucose- or galactose-
containing medium (Fig. 5). We also found no diﬀerences in
mitochondrial iron content between the strains overexpressing
the wild type, K475M and E598A mutant proteins (not
shown).
The lack of a dominant-negative eﬀect of the K475M and
E598A alleles of ATM1 could result from preferential associ-
ation between wild type proteins, such that even in the pres-
ence of an excess of mutant monomers, suﬃcient numbers of
functional wild type dimers are formed to allow for cellular
survival. Alternatively, our observations may indicate that the
two NBDs of the Atm1p homodimer are actually functionally
asymmetric and that only one active ATPase is required for
function. ABC transporters in which the two NBDs are known
Fig. 5. Test for dominant-negative eﬀects of the Walker A (K475M) and Walker B (E598A) mutants on wild type yeast. The wild type, K475M, or
E598A alleles of ATM1 were expressed in WT cells under the control of the galactose inducible GAL1 promoter in pYES 2.0. Equal numbers of cells
from each strain were serially diluted and dotted onto a -URA plate containing either glucose or galactose.
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several that perform non-classical ABC functions (i.e., they are
proteins that do not simply translocate substrates across
membranes in an ATP-dependent manner). For example, the
sulfonylurea receptors (SUR1, 2A, 2B) are ABC proteins that
function as regulators of ATP sensitive potassium channels
[35], and the CFTR functions as both a chloride channel and a
regulator of other plasma membrane ion channels [12,36]. The
potential asymmetry of the Atm1p ATPase suggests that it
may also perform a function other than that of an ATP-de-
pendent transporter. However, understanding the reason for
the lack of a dominant-negative eﬀect of the mutant proteins,
and determining the true role of Atm1p in Fe-S cluster bio-
synthesis will require further in vitro and in vivo studies.
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